Aptorum Group Limited is a clinical stage biopharmaceutical company based in New York, NY. They are dedicated to discovering, developing, and commercializing therapeutic assets to treat diseases with unmet medical needs, particularly in oncology and infectious diseases. Their pipeline includes drug discovery platforms and a novel molecular-based rapid pathogen identification and detection diagnostics technology.
Aptorum Group is focused on facilitating the development of medical innovations that can significantly improve clinical and surgical experiences and meet current unmet medical needs. With a deep portfolio and strong life science development capabilities, they are driven by the enthralling market potential and growth prospects in the field of healthcare. Their mission is to tackle unmet medical needs and make a positive impact on patients' lives.
Generated from the website